Protocol biopsies should not (yet) be the standard of care in pediatric renal transplant recipients

Pediatric Transplantation

Volumn 10, Issue 7, 2006, Pages 766-767

  Shapiro, Ron ^a   Starzl, Thomas E ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD HEALTH CARE; CLINICAL PROTOCOL; EDITORIAL; HUMAN; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; PATIENT MONITORING; PEDIATRIC SURGERY; POSTOPERATIVE PERIOD; STANDARD; TREATMENT OUTCOME;

BIOPSY; CHILD; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION, HOMOLOGOUS;

EID: 33749567038     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2006.00572.x     Document Type: Editorial

References (27)

1. BURDICK JF, BESCHORNER WE, SMITH WJ, et al. Characteristics of early routine renal allograft biopsies. Transplantation 1984: 38: 679-684.
2. BURDICK JF, MCGRAW D, BENDER W, BESCHORNER WE, WILLIAMS GM, SOLEZ K. Renal allograft infiltrate in the absence of rejection. Transplant Proc 1984: 16: 1580-1582.
3. RUSH DN, JEFFERY JR, GOUGH J. Protocol biopsies in stable renal transplant patients under triple immunosuppression: Results at 6 months. Transplant Proc 1994: 26: 2576.
4. RUSH DN, JEFFERY JR, GOUGH J. Sequential protocol biopsies in renal transplant patients. Clinico-pathological correlations using the Ban. schema. Transplantation 1995: 59: 511-514.
5. RUSH DN, NICKERSON P, GOUGH J, et al. Beneficial effects of treatment of early subclinical rejection: A randomized study. J Am Soc Nephrol 1998: 9: 2129.
6. RUSH D, NICKERSON P, JEFFEREY J. Protocol biopsies in the management of renal allograft recipients. Curr Opin Nephrol Hyptertens 2000: 9: 615.
7. SERON D, MORESO F, BOVER J, et al. Early protocol renal allograft biopsies and graft outcome. Kidney Int 1997: 51: 310-316.
8. SERON D, MORESCO F, RAMON JM, et al. Protocol renal allograft biopsies and the design of clinical trials aimed to prevent or treat chronic allograft nephropathy. Transplantation 2000: 69: 1849-1855.
9. LIPMAN ML, SHEN Y, JEFFERY JR, et al. Immune-activation gene expression in clinically stable renal allograft biopsies: Molecular evidence for subclinical rejection. Transplantation 1998: 66: 1673-1681.
10. LEGENDRE C, THERVET E, SKHIRI H, et al. Histologic features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplant recipients. Transplantation 1998: 65: 1506-1509.
11. JAIN S, CURWOOD V, WHITE SA, FURNESS PN, NICHOLSON ML. Subclinical acute rejection detected using protocol biopsies in patients with delayed graft function. Transpl Int 2000: 13: S52-S55.
12. SHAPIRO R, RANDHAWA P, JORDAN ML, et al. An analysis of early renal transplant protocol biopsies - The high incidence of subclinical tubulitis. Am J Transplant 2001: 1: 47-50.
13. NANKIVELL BJ, FENTON-LEE CA, KUYPERS DR, et al. Effect of histological damage on long-term kidney transplant outcome. Transplantation 2001: 71: 515-523.
14. VERONESE FV, NORONHA IL, MANFRO RC, et al. Protocol biopsies in renal transplant patients: Three-years' follow up. Transplant Proc 2002: 34: 500-501.
15. GLOOR JM, COHEN AJ, LAGER DJ, et al. Subclinical rejection in tacrolimus-treated renal transplant recipients. Transplantation 2002: 73: 1965-1968.
16. QURESHI F, RABB H, KASISKE BL. Silent acute rejection during prolonged delayed graft function reduces kidney allograft survival. Transplantation 2002: 74: 1400-1404.
17. SHISHIDO S, ASANUMA H, NAKAI H, et al. The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol 2003: 14: 1046-1052.
18. BOHMIG GA, REGELE H, HORL WH. Protocol biopsies after kidney transplantation. Transpl Int 2005: 18: 131-139.
19. ISONIEMI H, TASKINEN E, HAYRY P. Histological chronic allograft damage index accurately predicts chronic renal allograft rejection. Transplantation 1994: 58: 1195-1198.
20. DIMENY E, WAHLBERG J, LARSSON E, FELLSTROM B. Can histopathological findings in early renal allograft biopsies identify patients at risk for chronic vascular rejection? Clin Transplant 1995: 9: 79-84.
21. BICKNELL GR, WILLIAMS ST, SHAW JA, PRINGLE JH, FURNESS PN, NICHOLSON ML. Differential effects of cyclosporine and tacrolimus on the expression of fibrosis-associated genes in isolated glomeruli from renal transplants. Br J Surg 2000; 87: 1569-1575.
22. LEHTONEN SR, TASKINEN EI, ISONIEMI HM. Histological alterations in implant and one-year protocol biopsy specimens of renal allografts. Transplantation 2001: 72: 1138-1144.
23. MORESO F, LOPEZ M, VALLEJOS A, et al. Serial protocol biopsies to quantify the progression of chronic transplant nephropathy in stable renal allografts. Am J Transplant 2001: 1: 82-88.
24. BABOOLAL K, JONES GA, JANEZIC A, GRITHS DR, JUREWICZ WA. Molecular and structural consequences of early renal allograft injury. Kidney Int 2002: 61: 686-696.
25. SERON D, MORESO F, FULLADOSA X, HUESO M, CARRERA M, GRINYO JM. Reliability of chronic allograft nephropathy diagnosis in sequential protocol biopsies. Kidney Int 2002: 61: 727-733.
26. BIRK PE, STANNARD KM, KONRAD HB, et al. Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children. Pediatr Transplant 2004: 8: 29-38.
27. FURNESS PN, PHILPOTT CM, CHORBADJIAN MT, et al. Protocol biopsy of the stable renal transplant: A multicenter study of methods and complication rates. Transplantation 2003: 76: 969-973.